Lily and Novo Nordisk

Meg Terrell: I thought it was interesting that they decided to cut prices on a drug which is made less necessary if the success of Monjaro really takes off. Lily has sold off what, 375 to about, it was trading 310 or something today. That 20 billion estimate and it's going to take years and those are drugs. But when you think about it off a 30 billion base,  that is some serious growth over the next few years.